Amrutanjan Health Care (NSE:AMRUTANJAN) Debt-to-Equity : 0.01 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Amrutanjan Health Care Debt-to-Equity?

Amrutanjan Health Care's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹3 Mil. Amrutanjan Health Care's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹14 Mil. Amrutanjan Health Care's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹2,885 Mil. Amrutanjan Health Care's debt to equity for the quarter that ended in Mar. 2024 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Amrutanjan Health Care's Debt-to-Equity or its related term are showing as below:

NSE:AMRUTANJAN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.01 Max: 0.03
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of Amrutanjan Health Care was 0.03. The lowest was 0.00. And the median was 0.01.

NSE:AMRUTANJAN's Debt-to-Equity is ranked better than
99.88% of 842 companies
in the Drug Manufacturers industry
Industry Median: 0.3 vs NSE:AMRUTANJAN: 0.01

Amrutanjan Health Care Debt-to-Equity Historical Data

The historical data trend for Amrutanjan Health Care's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amrutanjan Health Care Debt-to-Equity Chart

Amrutanjan Health Care Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.01

Amrutanjan Health Care Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															-	N/A	-	N/A	0.01

Competitive Comparison of Amrutanjan Health Care's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Amrutanjan Health Care's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amrutanjan Health Care's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amrutanjan Health Care's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Amrutanjan Health Care's Debt-to-Equity falls into.

Amrutanjan Health Care Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Amrutanjan Health Care's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.315	+	13.968)	/	2884.883
	=	0.01

Amrutanjan Health Care's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(3.315	+	13.968)	/	2884.883
	=	0.01

Amrutanjan Health Care (NSE:AMRUTANJAN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Amrutanjan Health Care Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Amrutanjan Health Care's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Amrutanjan Health Care (NSE:AMRUTANJAN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amrutanjan Health Care Ltd (NSE:AMRUTANJAN) » Definitions » Debt-to-Equity

Traded in Other Exchanges

590006:India

Address

No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004

Website

https://www.amrutanjan.com

Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkin, and inhaler. Geographically, it generates the majority of the revenue from India.

Amrutanjan Health Care (NSE:AMRUTANJAN) Headlines

No Headlines